Charles River Laboratories (CRL)

EBITDA Margin

15.02%

Quarterly · Period ending:

CRL logo

CRL EBITDA Margin

Latest reported15.02%
CRL Quarterly EBITDA Margin (32.96% → 15.02%)
High-resolution chart · PNG

CRL ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Charles River Laboratories EBITDA Margin — Quarterly
Period endingEBITDA Margin
26.9106%
25.5132%
20.4607%
31.1262%
26.9687%
32.9572%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.